tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Oramed Pharmaceuticals's activity chart (see below) currently has 22 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 65.33% with an average time for these price targets to be met of 776 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 09-Sep-2024. First documented stock forecast 04-Dec-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 20-May-2024
2 years 13 days ago
(09-Sep-2024)
2/5 (40%)
$19.21 (150.20%)
1449
Hold Since 12-Jan-2023
$2
$-2.67 (-57.17%)
3 years 4 months 5 days ago
(17-May-2023)
2/4 (50%)
$-1.38 (-40.83%)
175
Buy Since 11-Mar-2020
$35
4 years 4 months 6 days ago
(16-May-2022)
1/2 (50%)
$11.62 (49.70%)
320
Buy Since 18-Feb-2022
$20
$16.69 (504.23%)
4 years 7 months 4 days ago
(18-Feb-2022)
0/1 (0%)
$10.16 (103.25%)
Buy Since 03-Dec-2020
$40
$35.33 (756.53%)
4 years 10 months 13 days ago
(09-Nov-2021)
1/2 (50%)
$12.76 (46.84%)
181
What is ORMP (Oramed Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ORMP (Oramed Pharmaceuticals)?
Which analyst has the most public recommendations on ORMP (Oramed Pharmaceuticals)?
Which analyst is the currently most bullish on ORMP (Oramed Pharmaceuticals)?
Which analyst is the currently most reserved on ORMP (Oramed Pharmaceuticals)?
